DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Methoxyamine is an investigational drug.
There have been 6 clinical trials for Methoxyamine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2015.
The most common disease conditions in clinical trials are Lymphoma, Lung Neoplasms, and Carcinoma, Non-Small-Cell Lung. The leading clinical trial sponsors are National Cancer Institute (NCI), Case Comprehensive Cancer Center, and [disabled in preview].
There are three US patents protecting this investigational drug and thirty-five international patents.
Recent Clinical Trials for Methoxyamine
|Methoxyamine and Temozolomide in Treating Patients With Recurrent Glioblastoma||National Cancer Institute (NCI)||Phase 2|
|Methoxyamine, Pemetrexed Disodium, Cisplatin, and Radiation Therapy in Treating Patients With Stage IIIA-IV Non-small Cell Lung Cancer||National Cancer Institute (NCI)||Phase 1|
|Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Cisplatin and Pemetrexed||National Cancer Institute (NCI)||Phase 1/Phase 2|
Top disease conditions for Methoxyamine
Top clinical trial sponsors for Methoxyamine
|Drugname||Patent Number||Patent Title||Patent Assignee||Estimated Expiration|
|Methoxyamine||Start Trial||4-substituted pyrazolo[3,4-d]pyrimidine derivatives||Ortho Pharmaceutical Corporation (Raritan, NJ)||Start Trial|
|Methoxyamine||Start Trial||Macrolide compounds||American Cyanamid Company (Stamford, CT)||Start Trial|
|Methoxyamine||Start Trial||Benzo[1,8]naphthyridine derivatives, their preparation and the compositions which contain them||Laboratoire Roger Bellon (Seine, FR)||Start Trial|
|>Drugname||>Patent Number||>Patent Title||>Patent Assignee||>Estimated Expiration|
|Drugname||Country||Document Number||Estimated Expiration||Related US Patent|
|>Drugname||>Country||>Document Number||>Estimated Expiration||>Related US Patent|